BR0010563A - Composições isoladas de células da pele e métodos para seu uso - Google Patents

Composições isoladas de células da pele e métodos para seu uso

Info

Publication number
BR0010563A
BR0010563A BR0010563-5A BR0010563A BR0010563A BR 0010563 A BR0010563 A BR 0010563A BR 0010563 A BR0010563 A BR 0010563A BR 0010563 A BR0010563 A BR 0010563A
Authority
BR
Brazil
Prior art keywords
methods
skin cell
cell compositions
isolated skin
isolated
Prior art date
Application number
BR0010563-5A
Other languages
English (en)
Inventor
James D Watson
Lorna Strachan
Rene Onrust
Matthew Sleeman
Krishanand D Kumble
James G Murison
Original Assignee
Genesis Res & Dev Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Res & Dev Corp Ltd filed Critical Genesis Res & Dev Corp Ltd
Publication of BR0010563A publication Critical patent/BR0010563A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)

Abstract

Patente de Invenção: "COMPOSIçõES ISOLADAS DE CéLULAS DA PELE E MéTODOS PARA SEU USO". Polinucleotídeos isolados que codificam polipeptídeos expressos em células da pele de mamíferos são proporcionados, junto com vetores de expressão e células hospedeiras compreendendo tais polinucleotídeos isolados. Métodos para o uso de tais polinucleotídeos e polipeptídeos também são proporcionados.
BR0010563-5A 1999-05-14 2000-05-15 Composições isoladas de células da pele e métodos para seu uso BR0010563A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/312,283 US6573095B1 (en) 1998-04-29 1999-05-14 Polynucleotides isolated from skin cells
PCT/NZ2000/000075 WO2000069884A2 (en) 1999-05-14 2000-05-15 Compositions isolated from skin cells and methods for their use

Publications (1)

Publication Number Publication Date
BR0010563A true BR0010563A (pt) 2002-02-19

Family

ID=23210737

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010563-5A BR0010563A (pt) 1999-05-14 2000-05-15 Composições isoladas de células da pele e métodos para seu uso

Country Status (10)

Country Link
US (1) US6573095B1 (pt)
EP (1) EP1185555A4 (pt)
JP (1) JP2002543824A (pt)
KR (1) KR20020013543A (pt)
CN (1) CN1373774A (pt)
AU (1) AU4958800A (pt)
BR (1) BR0010563A (pt)
CA (1) CA2374045A1 (pt)
NZ (1) NZ515388A (pt)
WO (1) WO2000069884A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
US7294482B2 (en) * 1998-11-19 2007-11-13 Millennium Pharmaceuticals, Inc. EGF-like nucleic acids
CA2450402A1 (en) * 1998-12-22 2000-06-29 Genentech, Inc. Methods and compositions for inhibiting cancer cell growth comprising pro224
US20030190669A1 (en) * 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2001055333A2 (en) * 2000-01-25 2001-08-02 Hyseq, Inc. Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
AU2001260847A1 (en) * 2000-05-24 2001-12-03 Genesis Research And Development Corporation Limited Compositions isolated from skin cells and methods for their use
EP1307557A2 (en) 2000-08-02 2003-05-07 The Johns Hopkins University Endothelial cell expression patterns
AU2003236351A1 (en) * 2002-04-03 2003-10-27 Banyu Pharmaceutical Co., Ltd. Novel g protein-coupled receptor gene and protein bg8
US20040121362A1 (en) * 2002-06-20 2004-06-24 Whitney Gena S. Identification and modulation of a G-protein coupled receptor (GPCR), RAI-3, associated with chronic obstructive pulmonary disease (COPD) and NF-kappaB and E-selectin regulation
US20040259163A1 (en) * 2002-06-21 2004-12-23 Zymogenetics, Inc. Antibodies to mammalian adhesion protease peptides
JPWO2004042056A1 (ja) * 2002-11-06 2006-03-09 株式会社林原生物化学研究所 生理活性ポリペプチドとその抗体及びそれらの用途
US20050272067A1 (en) * 2004-03-10 2005-12-08 Macina Roberto A Compositions, splice variants and methods relating to cancer specific genes and proteins
JP2006137747A (ja) * 2004-10-14 2006-06-01 Hayashibara Biochem Lab Inc サイトカイン類及び／又はケモカイン類産生増強剤
WO2006069449A1 (en) * 2004-12-29 2006-07-06 The University Of British Columbia Chemokine receptor-independent immunomodulatory and anti-proliferative activity
CN109776656B (zh) * 2019-01-11 2022-03-11 广州领晟医疗科技有限公司 一种用于抑制血管新生的多肽tin7n及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
JP2000507101A (ja) 1996-03-19 2000-06-13 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ケモカインアルファ２
US5850020A (en) 1996-09-11 1998-12-15 Genesis Research & Development Corporation, Ltd. Materials and method for the modification of plant lignin content
WO1998032858A2 (en) 1997-01-23 1998-07-30 Schering Corporation Mammalian chemokines; receptors; reagents; uses
DE19817557A1 (de) 1998-04-09 1999-10-21 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe
US6573095B1 (en) 1998-04-29 2003-06-03 Genesis Research & Development Corporation Limited Polynucleotides isolated from skin cells
WO1999055865A1 (en) 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isolated from skin cells and methods for their use
AU2153500A (en) 1998-11-19 2000-06-05 Millennium Pharmaceuticals, Inc. Egf-like nucleic acids and polypeptides and uses thereof
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
EP1171462A2 (en) 1999-03-26 2002-01-16 Human Genome Sciences, Inc. 49 human secreted proteins
CA2370609A1 (en) 1999-04-20 2000-10-26 Zymogenetics, Inc. Adipocyte complement related protein homolog zacrp3
MXPA01012093A (es) 1999-05-27 2002-07-30 Zymogenetics Inc Proteina homologa zacrp7 relacionada al complemento de adipocitos.
AU6232300A (en) 1999-07-21 2001-02-13 Incyte Genomics, Inc. Receptors and associated proteins
WO2001010902A2 (en) 1999-08-11 2001-02-15 Curagen Corporation Nucleoc acids and secreted polypeptides encoded thereby
AU2404001A (en) 2000-01-06 2001-07-16 Protegene Inc. Human proteins having hydrophobic domains and dnas encoding these proteins

Also Published As

Publication number Publication date
JP2002543824A (ja) 2002-12-24
CA2374045A1 (en) 2000-11-23
CN1373774A (zh) 2002-10-09
EP1185555A2 (en) 2002-03-13
WO2000069884A2 (en) 2000-11-23
EP1185555A4 (en) 2004-05-19
KR20020013543A (ko) 2002-02-20
AU4958800A (en) 2000-12-05
WO2000069884A3 (en) 2001-02-15
US6573095B1 (en) 2003-06-03
NZ515388A (en) 2003-03-28

Similar Documents

Publication Publication Date Title
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
DE69737978D1 (de) Als 2f1 bezeichnetes rezeptorprotein
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
BRPI9811940A (pt) vetor de expressão para um polipeptídeo de ligação da interleucina-18 (il-18-bp), célula hospedeira procariótica transformada com o referido vetor, processo para produção de il-18-bp, proteína de fusão compreendendo o referido polipeptídeo, bem como il-18bp modificada.
DE69533923D1 (de) Cytokinin-designiertes lerk-5
BR9809816A (pt) Composições para cuidados pessoais contendo polìmeros enxertados enrijecidos.
NO950939L (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
BR9801652A (pt) Resorcinil-triazinas
DE69912870D1 (de) Kosmetische oder dermatologische Zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes Seidenprotein von Arachniden oder ein analoges Protein
BR9907189A (pt) Produtos da fração lipìdica do carotenóide de pepino do mar e métodos de uso
NO960743L (no) Cellulære preparater, deres fremstilling og terapeutiske anvendelse
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
ATE353955T1 (de) Durch zelloberflächenmoleküle induzierte makrophagenaktivierung
WO2000069884A3 (en) Compositions isolated from skin cells and methods for their use
NO20052363L (no) Interferon-alfa polypeptider og konjugater
IT1291859B1 (it) Perfezionamento nei dispositivi di tenuta stagna per bottone di comando di strumenti, particolarmente per la corona di carica e di
BR9306580A (pt) Xilanase molécula de dna isolda ou recombinada codificando umaxilanase sequência de dna célula hospedeira uso de uma xilanase e molécula de dna isolada ou recombinante
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
WO2000029448A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
BR0009396A (pt) Lipase, composição detergente, sequência de dna, vetor de expressão, célula hospedeira transformada, e, processo para produzir a lipase
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]